A recent study has found that medicines reconciliation provided by pharmacists can significantly reduce medicine discrepancies and may be associated with reductions in length of hospital stay and readmission.
The UK government currently recommends that all patients receive medicines reconciliation (MR) from a member of the pharmacy team within 24 hours of hospital admission to ensure accurate transfer of information about medication between the different care settings.
This is the first UK randomised controlled trial of pharmacy-provided MR and was carried out by the Pharmacy department at Cambridge University Hospital Foundation Trust and the University of East Anglia (UEA).
Results demonstrate a significant reduction in unintentional medication discrepancies and a potential association with reduced length of patient stay and hospital emergency readmission.
Two hundred patients at Cambridge University Hospitals NHS Foundation Trust were randomised to either gold standard medicines reconciliation or usual care. Researchers found that nearly all medication discrepancies identified at both points of transfer were addressed in the intervention arm.
In those patients who received usual care, which may or may not have included pharmacy provided medicines reconciliation, a large number of discrepancies remained at both time points.
Principal investigator Brit Cadman said: "This project suggests that whilst significant resources are required to undertake thorough medicines reconciliations this may be justified by cost savings realised through reduced length of stay and rehospitalisation. The study found that, in line with international evidence, thorough medicines reconciliation takes on average 45 minutes per patient. Interestingly only 15 minutes was spent on medicines reconciliation per patient in the usual care group."
The study is published in British Medical Journal Open.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
